TMCnet News

Indonesia Clinical Lateral Flow Assay Markets Trends & Forecasts 2016-2021 - Research and Markets
[July 29, 2016]

Indonesia Clinical Lateral Flow Assay Markets Trends & Forecasts 2016-2021 - Research and Markets


Research and Markets has announced the addition of the "Clinical Lateral Flow Assay Markets in Indonesia: Trends & Forecasts" report to their offering.

Indonesia's healthcare market is on the verge of rapid growth at this point, as the government is taking steps to improve access to quality healthcare for its population by implementing universal health coverage (UHC) for 100% of its population by 2019. In addition to this, regulations promoting e-commerce as a measure to tackle corruption practices in the public sector is also changing the face of healthcare system in Indonesia.

This report analyses Indonesian demand for clinical LFIA rapid tests and forecasts its growth. The market size by unit shipments for these products is expected to grow at a CAGR of 13% between 2016 and 2021. However, revenue growth is expected to grow at a lower rate, at around 10.2%. The increasing significance of community healthcare centers in Indonesia as primary healthcare providers is one of the major fators driving this growth. However, e-commerce regulations are expected to impact revenues and profit margins from these products.



This report assesses the regulatory landscape of the healthcare sector with a particular focus on the criteria important for foreign companies interested in this market. It also assesses the prevalence of various diseases in each provinces of Indonesia, which is critical for companies to develop strategies based on the tests that will have highest demand. Finally, the report analyses key brands available in Indonesia, its manufacturers, and distributors.

Key Topics Covered:


Executive Summary

Introduction

Chapter 1: Market Overview

Chapter 2: Regulatory Trends & Insights Relevant for IVD Sector

Chapter 3: Industry Structure

Chapter 4: Statistics of Highly Prevalent Infectious Diseases in Indonesia

Chapter 5: Company Profiles

- Alere Inc.

- bioMerieux SA

- Blue Cross Bio-Medical (Beijing) Co., Ltd.

- CTK Biotech, Inc

- InTec Products Inc.

- Nova Century Scientific, Inc

- PT Anugrah Argon Medika (AAM)

- PT Enseval Medika Prima (EMP)

- PT Enseval Putera Megatrading (EPM)

- PT Fokus Diagnostic Indonesia

- PT Oncoprobe Utama

- PT Pacific Biotekindo Intralab

- PT Primarindo Multi Alkestama

- PT Rajawali Nusindo

- PT Sekarguna Medika

- PT Syifana Berkah Indonesia

For more information visit http://www.researchandmarkets.com/research/x2kmbg/clinical_lateral


[ Back To TMCnet.com's Homepage ]